Streetbeat News

SNES

SenesTech, Inc.

https://www.senestech.com

Industry

Chemicals - Specialty

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Open

2.43

Mkt cap

2.3M

Volume

231K

High

2.43

P/E Ratio

0.02

52-wk high

9.80

Low

2.12

Div yield

N/A

52-wk low

1.90

In Monday's after-market session, several healthcare stocks experienced significant movements. SenesTech (SNES) saw a 42.0% increase, while Centessa Pharmaceuticals (CNTA) dropped by 10.6%. Other notable gainers include TC BioPharm (TCBP), Heart Test Laboratories (HSCS), UpHealth (UPH), AcelRx Pharmaceuticals (ACRX), and Sientra (SIEN). On the losing side, Redhill Biopharma (RDHL), OneMedNet (ONMD), Tharimmune (THAR), Envoy Medical (COCH), and Leap Therapeutics (LPTX) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 9:31 pm

SenesTech shares have risen following the announcement of the launch of their new product, Evolve Soft Bait, at Ace Hardware franchise locations in California.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:30 pm

SenesTech, Inc. has launched its EVOLVE Soft Bait fertility control product in select Ace Hardware franchise locations in California. This move represents an expansion of the company's distribution channels for its innovative pest control solution.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:02 pm

Anavex Life Sciences Corp. (AVXL) shares dropped by 10% after reporting a Q4 net loss of $10.1 million, or 12 cents per share, compared to a net loss of $14.3 million, or 18 cents per share, in the same period last year. Other stocks experienced significant movements in Monday's mid-day session, with notable gainers including RedHill Biopharma Ltd. (RDHL), Biodexa Pharmaceuticals Plc (BDRX), and Tharimmune, Inc. (THAR), among others. Losers included 10X Capital Venture Acquisition Corp. II (VCXA), BioNexus Gene Lab Corp. (BGLC), and HCW Biologics Inc. (HCWB). Affirm Holdings, Inc. (AFRM) saw a jump of 13.7% following positive 'buy now, pay later' predictions for Cyber Monday.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 6:41 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Redhill Biopharma (RDHL) saw a sharp increase of 118.7%, while Tharimmune (THAR) and Apollomics (APLM) rose by 39.13% and 33.37%, respectively. Conversely, Impel Pharmaceuticals (IMPL) and Nuwellis (NUWE) saw declines of 17.7% and 16.69%. Other notable movers included 60 Degrees (SXTP), Sunshine Biopharma (SBFM), Olema Pharmaceuticals (OLMA), Envoy Medical (COCH), Kura Oncology (KURA), SenesTech (SNES), and Kiora Pharmaceuticals (KPRX).

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 1:07 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. GeneDx Holdings (WGS) saw a 39.7% increase, while Evelo Biosciences (EVLO) dropped 19.7%. Other notable gainers include Scilex Holding (SCLX), Modular Medical (MODD), Sight Sciences (SGHT), Gyre Therapeutics (GYRE), and Pasithea Therapeutics (KTTA). On the losing side, Leap Therapeutics (LPTX), SenesTech (SNES), Virios Therapeutics (VIRI), MSP Recovery (LIFW), and Biophytis (BPTS) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

November 24, 2023 | 5:31 pm

SenesTech, Inc. has expanded its distribution through DIY Pest Control with an initial stocking order for its Evolve Soft Bait fertility control product. Evolve is a nonlethal rodent fertility control solution that is highly palatable to rats and can be used in various environments. The product aims to manage rodent populations by reducing their fertility. SenesTech's CEO, Joel Fruendt, expressed satisfaction with the expanded distribution relationship, which builds on the past success of distributing ContraPest products. DIY Pest Control's President, Fletcher Cline, anticipates Evolve will be a strong seller, complementing the demand for other SenesTech products like the Elevate and Isolate Bait Systems.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:04 pm

The Children's Place, Inc. (NASDAQ:PLCE) shares dropped by approximately 25% due to weaker than expected quarterly earnings, with adjusted earnings of $3.22 per share compared to estimates of $3.56 per share. Despite sales exceeding estimates, the stock price fell significantly. Other stocks experienced movements in Thursday's mid-day session, with various companies reporting earnings, clinical trial updates, mergers, and public offerings.

Portfolio Pulse from Lisa Levin

November 16, 2023 | 6:11 pm

Palo Alto Networks, Inc. (NASDAQ:PANW) shares dropped by approximately 5% in pre-market trading despite reporting Q1 earnings and revenue that beat analyst estimates. The decline is attributed to the company's lowered full-year 2024 total billings forecast. Other stocks experienced various movements in pre-market trading, with some notable gainers and losers listed.

Portfolio Pulse from Lisa Levin

November 16, 2023 | 1:08 pm

SenesTech, Inc. (NASDAQ:SNES) announced a 1-for-12 reverse stock split effective November 16, 2023, after market close. The stock will trade on a split-adjusted basis starting November 17, 2023. The split was approved by stockholders and will reduce the number of issued shares from 5,899,060 to approximately 491,589. Adjustments will be made to equity awards and warrants, with fractional shares rounded up or down depending on how they are held.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 2:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.